Format
Items per page
Sort by

Send to:

Choose Destination

Results: 12

Cited In for PubMed (Select 18762918)

1.

Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy.

Greenwald MK, Comer SD, Fiellin DA.

Drug Alcohol Depend. 2014 Nov 1;144:1-11. doi: 10.1016/j.drugalcdep.2014.07.035. Epub 2014 Aug 19.

PMID:
25179217
2.

Kappa-opioid receptor signaling in the striatum as a potential modulator of dopamine transmission in cocaine dependence.

Trifilieff P, Martinez D.

Front Psychiatry. 2013 Jun 3;4:44. doi: 10.3389/fpsyt.2013.00044. eCollection 2013.

3.

The endogenous opioid system in cocaine addiction: what lessons have opioid peptide and receptor knockout mice taught us?

Yoo JH, Kitchen I, Bailey A.

Br J Pharmacol. 2012 Aug;166(7):1993-2014. doi: 10.1111/j.1476-5381.2012.01952.x. Review.

4.

Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects.

Wand GS, Weerts EM, Kuwabara H, Frost JJ, Xu X, McCaul ME.

Psychoneuroendocrinology. 2011 Nov;36(10):1453-9. doi: 10.1016/j.psyneuen.2011.03.019. Epub 2011 May 6.

5.

Imaging receptor changes in human drug abusers.

Cosgrove KP.

Curr Top Behav Neurosci. 2010;3:199-217. doi: 10.1007/7854_2009_24. Review.

6.

Differential response to IV carfentanil in chronic cocaine users and healthy controls.

Minkowski CP, Epstein D, Frost JJ, Gorelick DA.

Addict Biol. 2012 Jan;17(1):149-55. doi: 10.1111/j.1369-1600.2010.00256.x. Epub 2010 Nov 4.

7.

OPRM1 gene variants modulate amphetamine-induced euphoria in humans.

Dlugos AM, Hamidovic A, Hodgkinson C, Shen PH, Goldman D, Palmer AA, de Wit H.

Genes Brain Behav. 2011 Mar;10(2):199-209. doi: 10.1111/j.1601-183X.2010.00655.x. Epub 2010 Nov 2.

8.

What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?

Cumming P, Caprioli D, Dalley JW.

Br J Pharmacol. 2011 Aug;163(8):1586-604. doi: 10.1111/j.1476-5381.2010.01036.x. Review.

9.

Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients.

Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B, Boyd SJ, Copersino ML, Frost JJ, Gorelick DA.

Biol Psychiatry. 2010 Oct 15;68(8):697-703. doi: 10.1016/j.biopsych.2010.05.003. Epub 2010 Jul 1.

10.

Pain imaging in the emerging era of molecular medicine.

Stohler CS, Zubieta JK.

Methods Mol Biol. 2010;617:517-37. doi: 10.1007/978-1-60327-323-7_38.

11.

Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.

Zhou Y, Proudnikov D, Yuferov V, Kreek MJ.

Brain Res. 2010 Feb 16;1314:235-52. doi: 10.1016/j.brainres.2009.11.015. Epub 2009 Nov 12. Review.

12.

Role of mu- and delta-opioid receptors in the nucleus accumbens in cocaine-seeking behavior.

Simmons D, Self DW.

Neuropsychopharmacology. 2009 Jul;34(8):1946-57. doi: 10.1038/npp.2009.28. Epub 2009 Mar 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk